Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays
- 9 March 2010
- journal article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 38 (3), 487-501
- https://doi.org/10.1177/0192623310363813
Abstract
The two-year rodent bioassay remains the mainstay for carcinogenicity testing, although numerous difficulties have been identified. Fundamentally, a chemical can increase the risk of cancer (1) by damaging DNA directly (DNA reactive) or (2) indirectly by increasing the number of DNA replications (non–DNA reactive). Mechanistic research has identified numerous precursor lesions in the sequence of key events necessary for neoplasia development. Based on these concepts, the author has proposed a short-term (thirteen-week) assay for screening for carcinogenic potential based on a mode of action analysis and on readily available, identifiable preneoplastic changes. A screening assay that detects all potential rodent hepatocarcinogens has been previously identified ( Toxicol Pathol32 [2004], 393–401) including increased liver weight, hepatocellular necrosis, hypertrophy, and cytomegaly. Labeling index for DNA replication might supply additional support. These markers have high sensitivity but low specificity. However, most chemicals can be appropriately classified as to their mode(s) of action for hepatocarcinogenesis with follow-up mechanistic studies, and a rational evaluation of their relevance to humans can be made. A similar process can be envisioned for other tissues for evaluation for carcinogenic potential.Keywords
This publication has 94 references indexed in Scilit:
- Time-course comparison of xenobiotic activators of CAR and PPARα in mouse liverToxicology and Applied Pharmacology, 2009
- Age-specific incidence of cancer: Phases, transitions, and biological implicationsProceedings of the National Academy of Sciences of the United States of America, 2008
- Ah Receptor Binding to its Cognate Response Element is Required for Dioxin-Mediated ToxicityToxicological Sciences, 2008
- Advances in Chemical Carcinogenesis: A Historical Review and ProspectiveCancer Research, 2008
- The Association Between Statins and Cancer Incidence in a Veterans PopulationJNCI Journal of the National Cancer Institute, 2008
- The PPARα-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPARαToxicological Sciences, 2007
- Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls–iron interaction: Absence in the Cyp1a2(−/−) knockout mouseBiochemical and Biophysical Research Communications, 2005
- Tamoxifen: evidence by 32P–postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4–hydroxytamoxifen as a proximate metaboliteCarcinogenesis: Integrative Cancer Research, 1994
- Mechanism of Action and Biological Profile of HMG CoA Reductase InhibitorsDrugs, 1988
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences of the United States of America, 1971